[EN] AMINOHETEROARYL COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS<br/>[FR] COMPOSES AMINOHETEROARYLES EN TANT QU'INHIBITEURS DES PROTEINES TYROSINE KINASES
申请人:PFIZER
公开号:WO2006021886A1
公开(公告)日:2006-03-02
Aminoheteroaryl compounds are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.
PHOSPHORUS CONTAINING COMPOUNDS AS PROTEIN KINASE INHIBITORS
申请人:Hu Baihua
公开号:US20120220551A1
公开(公告)日:2012-08-30
The present invention relates to compounds represented by formula (I), which can modulate the activity of protein kinases. The invention also relates to a composition containing a compound of formula (I), and a method for synthesizing and using such compound for preventing or treating ALK or cMet mediated disorders or conditions.
[EN] PYRAZOLE-SUBSTITUTED AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS<br/>[FR] COMPOSES AMINOHETEROARYLE A SUBSTITUTION PYRAZOLE SERVANT D'INHIBITEURS DE PROTEINE KINASE
申请人:PFIZER
公开号:WO2006021881A2
公开(公告)日:2006-03-02
Compounds of formula (1) are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.
Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
申请人:Cui Jean Jingrong
公开号:US20060128724A1
公开(公告)日:2006-06-15
Compounds of formula 1
are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.
Aminoheteroaryl compounds as protein kinase inhibitors
申请人:Cui Jean Jingrong
公开号:US20050009840A1
公开(公告)日:2005-01-13
Aminopyridine and aminopyrazine compounds of formula (1), compositions including these compounds, and methods of their use are provided. Preferred compounds of formula 1 have activity as protein kinase inhibitors, including as inhibitors of c-MET.